Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry D Hinds

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Metabolites|May 26, 2026
Anatomical Atlas of Kinase Responsiveness to Weight Gain: Adipose Depot Reprogramming in Diet-Induced AdiposityWang-Hsin Lee, Zachary A Kipp, Sally N Pauss, et al.
Molecular Endocrinology (Baltimore, Md.)|June 17, 2014
FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγLance A Stechschulte, Terry D Hinds, Saja S Khuder, et al.
Molecular Endocrinology (Baltimore, Md.)|June 17, 2014
FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathwayLance A Stechschulte, Terry D Hinds, Simona S Ghanem, et al.
Biochemistry|September 6, 2008
Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat proteinsAnanya Banerjee, Sumudra Periyasamy, Irene M Wolf, et al.
The Journal of Biological Chemistry|October 28, 2016
Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) αJoseph S Marino, Lance A Stechschulte, David E Stec, et al.
Physiological Genomics|May 11, 2019
RNA sequencing in human HepG2 hepatocytes reveals PPAR-α mediates transcriptome responsiveness of bilirubinDarren M Gordon, Thomas M Blomquist, Scott A Miruzzi, et al.
Reactive Oxygen Species (Apex, N.C.)|January 31, 2018
A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase ActivitySamuel O Adeosun, Kyle H Moore, David M Lang, et al.
Plos One|April 13, 2016
Bilirubin Binding to PPARα Inhibits Lipid AccumulationDavid E Stec, Kezia John, Christopher J Trabbic, et al.
Frontiers in Pharmacology|January 4, 2021
Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-HydroxybutyrateTerry D Hinds, Justin F Creeden, Darren M Gordon, et al.
Plos One|May 22, 2013
Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemiaLarisa V Fedorova, Komal Sodhi, Cara Gatto-Weis, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Metabolites|May 26, 2026
Anatomical Atlas of Kinase Responsiveness to Weight Gain: Adipose Depot Reprogramming in Diet-Induced AdiposityWang-Hsin Lee, Zachary A Kipp, Sally N Pauss, et al.
Molecular Endocrinology (Baltimore, Md.)|June 17, 2014
FKBP51 controls cellular adipogenesis through p38 kinase-mediated phosphorylation of GRα and PPARγLance A Stechschulte, Terry D Hinds, Saja S Khuder, et al.
Molecular Endocrinology (Baltimore, Md.)|June 17, 2014
FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathwayLance A Stechschulte, Terry D Hinds, Simona S Ghanem, et al.
Biochemistry|September 6, 2008
Control of glucocorticoid and progesterone receptor subcellular localization by the ligand-binding domain is mediated by distinct interactions with tetratricopeptide repeat proteinsAnanya Banerjee, Sumudra Periyasamy, Irene M Wolf, et al.
The Journal of Biological Chemistry|October 28, 2016
Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) αJoseph S Marino, Lance A Stechschulte, David E Stec, et al.
Physiological Genomics|May 11, 2019
RNA sequencing in human HepG2 hepatocytes reveals PPAR-α mediates transcriptome responsiveness of bilirubinDarren M Gordon, Thomas M Blomquist, Scott A Miruzzi, et al.
Reactive Oxygen Species (Apex, N.C.)|January 31, 2018
A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase ActivitySamuel O Adeosun, Kyle H Moore, David M Lang, et al.
Plos One|April 13, 2016
Bilirubin Binding to PPARα Inhibits Lipid AccumulationDavid E Stec, Kezia John, Christopher J Trabbic, et al.
Frontiers in Pharmacology|January 4, 2021
Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-HydroxybutyrateTerry D Hinds, Justin F Creeden, Darren M Gordon, et al.
Plos One|May 22, 2013
Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemiaLarisa V Fedorova, Komal Sodhi, Cara Gatto-Weis, et al.
Pageof 11